xmlui.themes.about.link
Visualizar por autor "Gironella, Mercedes"
Mostrando ítems 1-3 de 3
-
High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience
González-Calle, Verónica; Rodríguez-Otero, Paula; Calasanz, María J.; Guijarro, Manuela; Martínez-López, Joaquín; Rosiñol, Laura; Hernández, Miguel T.; Teruel, Ana I.; Gironella, Mercedes; Oriol, Albert; Rubia, Javier de la; González-Rodríguez, Ana P.; Bargay, Joan; Sureda, Anna; Ocio San Miguel, Enrique María; Lahuerta, Juan J.; Bladé, Joan; San Miguel, Jesús F.; Mateos, María V.; [et al.] (Wolters Kluwer Health, 2024)
-
Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis
Cuenca, Isabel; Alameda, Daniel; Sanchez Vega, Beatriz; Gomez Sanchez, David; Alignani, Diego; Lasa, Marta; Onecha, Esther; Lecumberri, Ramón; Prosper, Felipe; Ocio San Miguel, Enrique María; González, Maria Esther; García de Coca, Alfonso; Rubia, Javier de la; Gironella, Mercedes; Palomera, Luis; Oriol, Albert; Casanova, María; Cabañas, Valentín; Taboada, Francisco; [et al.] (Nature Publishing Group, 2021)
-
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial
Puig, Noemi; Hernández, Miguel T.; Rosiñol, Laura; González, Esther; Arriba, Felipe de; Oriol, Albert; González-Calle, Verónica; Escalante, Fernando; Rubia, Javier de la; Gironella, Mercedes; Ríos, Rafael; García-Sánchez, Ricarda; Arguiñano, José M.; Alegre, Adrián; Martín, Jesús; Gutiérrez, Norma. C. Gutiérrez; Calasanz, María J.; Martín, María L.; Couto, María del Carmen; [et al.] (Nature Pub. Group, 2021)